Time for AI to Deliver
COVID-19 Impact On Radiology
With the majority of non-urgent diagnostic procedures postponed in the early months of the pandemic, PACS are currently underutilized. Yet, despite the reduced volume of imaging studies at this time, radiology must remain ready for a spike in utilization. Once procedures return to their pre-pandemic or “new normal” schedules, the volume could jump on a moment’s notice. Imaging is expected to be there for patients, and 100% operational for when procedures come roaring back. Our focus at Dicom systems is to be the support mechanism for physicians and for medical imaging.
Dicom Systems Aims To Make Enterprise Imaging AI More Accessible
Opportunities For Deep Learning In Enterprise Imaging
Can the algorithms, once implemented, learn from the patient population?
To date, the FDA has cleared or approved “locked” algorithms only. They define a “locked” algorithm as one that provides the same result each time the same input is applied to it and does not change. There is currently no approval for “learning” algorithms. These are described by the FDA as adaptive algorithms, for which the current regulatory frameworks were not designed. However, Dr. Chang, a panelist at a recent FDA workshop, shared that the FDA is now aware that continuous learning is one of the primary benefits of AI, and believes FDA approval for adaptive algorithms is not too far off.
Can AI be available to other disciplines, besides imaging? Can imaging and non-imaging data be combined in a deep learning algorithm?
Can AI help thwart a pandemic by identifying animal viruses?
Scientists estimate that 1.67 million viruses exist on earth. A fraction of the 1M+ animal viruses have the potential to “jump species,” a process called zoonotic spillover. Whether or not a virus can make such a leap and cause the next pandemic depends on a complex combination of factors related to ecology, viral evolution, and human immunity.